ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,271Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 890

$1.44M Total Retail Price of All Prescriptions

Rank: 15 out of 890

1,023 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 1,023 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

28% of this provider’s 1,023 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

4% of this provider’s 20,505 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 1,167 753 S3 1 3
FUROSEMIDE 782 626 2 7
POTASSIUM CHLORIDE 765 617 3 11
LEVOTHYROXINE SODIUM 680 560 4 2
GABAPENTIN 579 472 5 12
LISINOPRIL 545 427 6 4
NEXIUM 524 395 7 14
OMEPRAZOLE 518 372 8 8
METFORMIN HCL 464 356 9 6
MELOXICAM 459 379 10 18
AMLODIPINE BESYLATE 444 372 11 1
SIMVASTATIN 427 354 12 5
ZOLPIDEM TARTRATE 391 294 13 19
METOPROLOL TARTRATE 375 276 14 15
HYDROCHLOROTHIAZIDE 364 309 15 9
METOPROLOL SUCCINATE 334 242 16 17
CLOPIDOGREL 323 251 17 28
GLIMEPIRIDE 323 261 17 27
DONEPEZIL HCL 318 318 19 30
PRAVASTATIN SODIUM 311 255 20 10
ATORVASTATIN CALCIUM 270 226 21 13
WARFARIN SODIUM 270 229 21 24
CITALOPRAM HBR 264 217 23 20
LISINOPRIL-HYDROCHLOROTHIAZIDE 243 148 24 21
ALLOPURINOL 240 154 25 31
PLAVIX 237 192 26 42
SINGULAIR 227 151 27 79
AZITHROMYCIN 223 140 28 37
CLONIDINE HCL 217 154 29 35
NAMENDA 209 203 30 36
NIFEDIPINE ER 208 162 31 75
SERTRALINE HCL 201 175 32 26
CIPROFLOXACIN HCL 198 155 33 58
SULFAMETHOXAZOLE-TRIMETHOPRIM 193 142 34 76
LANTUS 189 116 35 50
TRAMADOL HCL 188 161 36 16
CARVEDILOL 168 151 37 22
LYRICA 164 112 38 71
DIGOXIN 162 138 39 65
RANITIDINE HCL 161 124 40 49
ATENOLOL 158 133 41 23
CELEBREX 155 145 42 91
AMITRIPTYLINE HCL 153 137 R 43 43
QUETIAPINE FUMARATE 153 138 43 73
CEPHALEXIN 150 105 45 119
MONTELUKAST SODIUM 146 94 46 130
COLCRYS 144 85 47 150
PREDNISONE 143 101 48 47
PROAIR HFA 141 71 49 55
POLYETHYLENE GLYCOL 3350 139 101 50 67
PANTOPRAZOLE SODIUM 138 116 51 34
LOVASTATIN 136 100 52 46
ISOSORBIDE MONONITRATE ER 129 117 53 60
RAMIPRIL 126 110 54 80
NAPROXEN 126 94 54 84
KLOR-CON M20 119 98 56 72
FLUOXETINE HCL 118 84 57 63
BISOPROLOL-HYDROCHLOROTHIAZIDE 115 75 58 122
MEGESTROL ACETATE 114 103 R 59 92
BUSPIRONE HCL 114 66 59 133
PROMETHAZINE HCL 113 72 R 61 104
ADVAIR DISKUS 110 52 62 52
DIOVAN HCT 109 63 63 48
CYMBALTA 106 57 64 45
LIPITOR 104 82 65 77
TAMSULOSIN HCL 103 87 66 32
DICLOFENAC SODIUM 102 97 67 96
PHENYTOIN SODIUM EXTENDED 102 47 67 111
BUMETANIDE 101 70 69 134
ALPRAZOLAM 101 94 69 95
MECLIZINE HCL 100 91 71 97
ROPINIROLE HCL 98 90 72 93
ESTRADIOL 97 85 R 73 118
INSULIN SYRINGE 97 68 73 99
CYCLOBENZAPRINE HCL 97 37 R 73 64
ALENDRONATE SODIUM 96 82 76 38
CEFTRIAXONE 96 83 76 239
DIOVAN 96 73 76 33
FLUCONAZOLE 95 62 79 155
AMLODIPINE BESYLATE-BENAZEPRIL 94 81 80 41
CRESTOR 94 88 80 25
PREMARIN 93 79 R 82 105
METOLAZONE 93 62 82 217
GLIPIZIDE 92 63 84 62
PAROXETINE HCL 91 75 85 68
SPIRIVA 91 51 85 66
TRAZODONE HCL 89 62 87 40
ACTOS 86 66 88 88
TRILIPIX 82 36 89 200
NOVOLIN R 82 44 89 153
CARAFATE 78 76 91 261
SUCRALFATE 76 75 92 158
NITROGLYCERIN PATCH 75 73 93 252
PROPRANOLOL HCL 75 54 93 141
IBUPROFEN 74 28 95 101
ONGLYZA 74 46 95 146
TRIAMTERENE-HCTZ 73 50 97 61
CLOTRIMAZOLE-BETAMETHASONE 73 58 97 152
TRAMADOL HCL-ACETAMINOPHEN 71 47 99 117
CARISOPRODOL 71 30 R 99 69
OXYBUTYNIN CHLORIDE 68 51 101 139
LIDOCAINE HCL 68 61 101 301
METOCLOPRAMIDE HCL 67 62 103 125
ESCITALOPRAM OXALATE 67 38 103 51
LANSOPRAZOLE 64 45 105 171
FLUTICASONE PROPIONATE 64 35 105 39
DEXILANT 63 45 107 138
NASONEX 62 41 108 170
JANTOVEN 61 61 109 169
PRAMIPEXOLE DIHYDROCHLORIDE 61 40 109 175
SPIRONOLACTONE 61 48 109 85
HYDROXYZINE PAMOATE 61 33 R 109 205
KLOR-CON M10 60 41 113 165
ENALAPRIL MALEATE 58 50 114 56
MUPIROCIN 56 24 115 121
RISPERIDONE 55 43 116 78
DETROL LA 55 41 116 164
FAMOTIDINE 54 26 118 90
TORSEMIDE 54 31 118 159
AMITIZA 54 41 118 210
ZETIA 53 44 121 81
LEVETIRACETAM 52 20 122 137
HYDROCORTISONE 51 26 123 376
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 10, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.